- ￥2232
- AntibodySystem
- FQK11011
- France
- 2025年07月08日
- FCM
- Mouse
- Dog
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
源叶生物 十万种现货试剂速发，品质稳、品类全，实验不再等！Takara 秋促来袭，提取+反转录+定量套装仅 1200 元abinScience 体内级抗体 全年锁价 低至 ￥1200阿拉丁 22万+ 科研级产品现货速发，品质严控、科研无忧- 详细信息
- 文献和实验
- 技术资料
- 抗体名：
Anti-Dog Lymphoma Antibody (Mab231), FITC
- 抗体英文名：
Anti-Dog Lymphoma Antibody (Mab231), FITC
- 浓度：
0.5 mg/ml
- 应用范围：
FCM
- 宿主：
Mouse
- 适应物种：
Dog
- 保质期：
1 year
- 级别：
科研级
- 库存：
999
- 供应商：
AntibodySystem
- 克隆性：
Monoclonal
- 保存条件：
Store at 4°C for 12 months. Protect from light. Do not freeze.
- 亚型：
IgG2a
- 规格：
100T
| 宿主 | Mouse |
| 偶联物 | FITC |
| 种属反应性 | Dog |
| 状态 | Liquid |
| 保存溶液 | 0.01M PBS, pH 7.4, 0.2% BSA, 0.05% Proclin 300. |
| 浓度 | 0.5 mg/ml |
| 克隆类型 | Monoclonal |
| 同种型 | IgG2a |
| 应用 | FCM |
| 靶标 | Lymphoma |
| 内毒素水平 | Please contact with the lab for this information. |
| 稳定性和存储 | Store at 4°C for 12 months. Protect from light. Do not freeze. |
| 克隆号 | Mab231 |
| 备注 | For research use only. |
Currently, AntibodySystem's product lines cover multiple research areas, including 48 types of viruses and superbugs, parasites, tumors, Alzheimer's disease, Parkinson's disease, hypersensitivity and allergic reactions, immune suppression, and immune activation.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Chimerization of a Monoclonal Antibody for Treating Hodgkin's Lymphoma
follicles and at the rim of germinal centers (2 ). Consequently, Ber-H2 has been utilized as an immunotoxin by conjugating the antibody to the ribosome-inactivating toxin Saporin to treat four patients with refractory Hodgkin’s lymphoma
Generation of Antibody Molecules Through Antibody Engineering
domains of the heavy (V H ) and light (V L ) chains. Effector functions are determined by constant C H 2 and C H 3 domains. The picture is based on the crystal structure of an intact IgG2 anti-canine lymphoma MAb231 ( 2 ) (pdb entry 1IGT). The drawing
The Application of Monoclonal Antibodies in the Treatment of Lymphoma
lymphoma treated with a chimeric anti-CD20 mAb, and Maloney and co-workers (2 ) recently reported a 50% response rate in relapsed, low-grade, NHL, with a 10---11 mo duration. Encouragingly, patients in these studies did not raise antibody responses
技术资料暂无技术资料 索取技术资料
